ASTROLOGICALLY IT WAS SAID THAT MARKET WILL NOT TEST ITS LOWS WHICH IT HAD MADE YESTERDAY (5698) AND EXACTLY THE SAME HAD HAPPENED. SO WHAT NEXT???????????
AS SAID EARLIER THAT THE SOLAR ECLIPSE WHICH HAD CAUSED MUCH FALL FROM 5TH JAUNARY TO 11TH JANUARY HAD NOW MADE A FORCEFUL SOROS ENERGY CYCLE TO CREATE AN UPSWING WHICH MAY BE BEYOND IMAGINATION. THIS IS KNOWN AS DECEPTION ,WHICH I WAS TALKING ABOUT.
INFOSYS RESULT TODAY MAY LEAD TO VOLATILITY ON THE INDEX. FALL IN THE INFOSYS STOCK IS NOT RULED OUT AS IT ALWAYS HAPPEN WITH ITS RESULT DAY. HOWEVER THE FALL ,IN INDEX, IF ANY, DUE TO INFOSYS STOCK SHALL BE COVERED BY RISE IN HUL & RELIANCE, BANKS ETC. HENCE PART PROFIT SHOULD BE BOOKED IN I.T STOCKS, FOR A WHILE AND BANK STOCKS SHOULD BE BOUGHT FOR EXPIRY VIEW.
NOW SEE HOW BENEFICIAL HAVE BEEN THE BUYING IN NIFTY CALLS, SBI CALLS, ICICI BANK CALLS ETC , WHICH ALL HAVE LED TO SURGE IN HUGE PROFITS. HOLD ALL YOUR LONG POSITION TILL 6020-6040 BY NEXT WEEK.
ASTROLOGICALLY THERE WILL BE SOME SURPRISING MOVES IN DAYS TO COME, THOSE WHO KNOW IN ADVANCE WILL BE BENEFITED. BUY THE CALLS IN NIFTY & BANK STOCKS LIKE SBI, ICICI, ETC.
FOLLOWING STOCKS SHOULD BE CONSIDERED FOR DELIVERY AS WELL AS INTRA-DAY:
GUJRAT FLOURO ( 240.20) TGT 260-280-300++++ VERY SOON. ALSO RECOMMENDED SEVERAL TIMES IN PAST FROM 218-220
RENUKA SUGAR (91.15) TGT 93-97-99++++++++
IDFC (164.50) TGT 168-172-178-183++++++++
HUL( 304.80) TGT 309-311-316-319+++++ ACCUMULATE THIS STOCK AS MUCH AS YOU CAN FOR JANUARY SETTLEMENT & FEBRUARY( TGT 360-380+++ IN FEB )
BUY SELECT FERTILISER STOCKS, CHAMBAL, RCF ETC , REDINGTON, SUVEN, & MIDCAP PHARMA STOCKS......
Safe Harbor Statement:
Some forward looking statements on projections, estimates, expectations & outlook are included to enable a better comprehension of the Company prospects. Actual results may, however, differ materially from those stated on account of factors such as changes in government regulations, tax regimes, economic developments within India and the countries within which the Company conducts its business, exchange rate and interest rate movements, impact of competing products and their pricing, product demand and supply constraints.Nothing in this article is, or should be construed as, investment advice.
Disclaimer:
This is neither an offer nor a solicitation to purchase or sell securities. The information and views contained on this blog are believed to be reliable, but no responsibility (or liability) is accepted for errors of fact or opinion. Writers and contributors may be trading in, or have positions in the securities mentioned in their articles. Neither I (Vikas Srivastava) nor any of the contributors accepts any liability arising out of use of the above information/article. Reproduction in whole or in part without written permission is prohibited.
Some forward looking statements on projections, estimates, expectations & outlook are included to enable a better comprehension of the Company prospects. Actual results may, however, differ materially from those stated on account of factors such as changes in government regulations, tax regimes, economic developments within India and the countries within which the Company conducts its business, exchange rate and interest rate movements, impact of competing products and their pricing, product demand and supply constraints.Nothing in this article is, or should be construed as, investment advice.
Disclaimer:
This is neither an offer nor a solicitation to purchase or sell securities. The information and views contained on this blog are believed to be reliable, but no responsibility (or liability) is accepted for errors of fact or opinion. Writers and contributors may be trading in, or have positions in the securities mentioned in their articles. Neither I (Vikas Srivastava) nor any of the contributors accepts any liability arising out of use of the above information/article. Reproduction in whole or in part without written permission is prohibited.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.